SEC 13F Intelligence

Js Capital Management LLC / TXG

Js Capital Management LLC’s 10x Genomics Inc Position

Does Js Capital Management LLC own 10x Genomics Inc (TXG)? Not currently — the last reported position was 540.6K shares worth $81M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$81M
Q4 2021
Shares
540.6K
% of Portfolio
+3.66%
Quarters Held
10
position exited

Position History TXG

Reported value by quarter
Q3 ’19: $85MQ3 ’19Q4 ’19: $128MQ1 ’20: $88MQ1 ’20Q2 ’20: $95MQ3 ’20: $76MQ3 ’20Q4 ’20: $85MQ1 ’21: $94MQ1 ’21Q2 ’21: $106MQ3 ’21: $79MQ3 ’21Q4 ’21: $81Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2021540.6K$81M+3.66%
Q3 2021540.6K$79M+4.56%
Q2 2021540.6K$106M+5.12%
Q1 2021517.3K$94M+4.84%
Q4 2020599.4K$85M+4.06%
Q3 2020606.4K$76M+3.91%
Q2 20201.06M$95M+7.17%
Q1 20201.41M$88M+11.08%
Q4 20191.67M$128M+14.71%
Q3 20191.68M$85M+11.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Js Capital Management LLC’s full portfolio or all institutional holders of TXG.